Bright Minds Biosciences Inc. Insider Trading

DRUG

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

None

in the last two years

Get an email when DRUG's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Apr 28	Cormorant Asset Management, LP Large holder	SoldNo plan	109,331	$89.50	$9.79M	10%	Form 4

Apr 28No plan
Cormorant Asset Management, LP
Large holder · sold 109,331 at $89.50
$9.79M
10% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DRUG, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biotechnology · Pick stocks to compare with DRUG

CompareIntrinsic value

NEWBRY.XSTONewbury Pharmaceuticals AB

€0.08+15.03%40

HPHA.XETRHeidelberg Pharma AG

€2.01-3.37%10

MEDCL.XPARMedincell SA

€28.68+3.02%40

ZTEKZentek Ltd.

€0.33+0.60%40

XTXXFAdastra Holdings Ltd.

€0.08+0.00%40

XRTXXORTX Therapeutics Inc.

$0.99-1.00%10

VALNValneva SE Sponsored ADR

$5.63+2.18%0

TRIBTrinity Biotech plc Sponsored ADR

$6.43-2.02%10

Held by ETFs

DRUG is in 10 US ETFs. The largest of them, with DRUG's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DRUG

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.